Effect of a control project on clinical profiles and outcomes in buruli ulcer: A before/after study in bas-congo, democratic republic of congo

PLoS Neglected Tropical Diseases

Volumn 5, Issue 12, 2011, Pages

  Phanzu, Delphin Mavinga ^a,b   Suykerbuyk, Patrick ^b   Imposo, Désiré Bofunga B ^a   Lukanu, Philippe Ngwala ^c   Minuku, Jean Bedel Masamba ^d   Lehman, Linda F ^e   Saunderson, Paul ^e   de Jong, Bouke C ^b   Lutumba, Pascal Tshindele ^f   Portaels, Françoise ^b   Boelaert, Marleen ^b  

^a General Reference Hospital of Kimpese   (Congo)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c Central Office of the Rural Health Zone of Kimpese   (Congo)

^d Central Office of the Rural Health Zone of Nsona Mpangu   (Congo)

^e American Leprosy Missions   (United States)

^f Institut National de Recherche Biomedicale   (Congo)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURULI ULCER; COMMUNITY ASSESSMENT; COMPARATIVE STUDY; CONGO; CONTROLLED STUDY; FATALITY; FEMALE; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; OUTCOME ASSESSMENT; PATIENT CARE; RECURRENT INFECTION; SEX DIFFERENCE; CHILD; DEMOCRATIC REPUBLIC CONGO; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BURULI ULCER; CHILD; COMMUNICABLE DISEASE CONTROL; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855293741     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001402     Document Type: Article

References (30)

1. Portaels F, Silva MT, Meyers WM, (2009) Buruli ulcer. Clin Dermatol 27: 291-305.
2. Asiedu K, Etuaful S, (1998) Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg 59: 1015-1022.
3. Aujoulat I, Huguet-Ribas MP, Koïta Y, (1996) L'ulcère de Buruli: un problème de santé publique méconnu, appelant une mobilisation internationale. Dév Santé 125: 22-30.
4. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of Neglected Tropical Diseases. N Engl J Med 357: 1018-1027.
5. Andersen FO, (1965) Mycobacterial skin ulcers-Clinical experience. Cent Afr J Med 11: 131-135.
6. Smith JH, (1970) Epidemiologic observations on cases of Buruli ulcer seen in a hospital in the Lower Congo. Am J Trop Med Hyg 19: 657-663.
7. Meyers WM, Connor DH, McCullough B, Bourland J, Moris R, et al. (1974) Distribution of Mycobacterium ulcerans infection in Zaïre, including the report of new foci. Ann Soc Belge Méd Trop 54: 147-157.
8. Portaels F, (1989) Epidémiologie des ulcères à Mycobacterium ulcerans. Ann Soc Belge Méd Trop 69: 91-103.
9. Kibadi K, Tsakala M, Mputu-Yamba JB, Muyembe T, Kashongwe M, et al. (2003) Buruli ulcer in Angolese refugees in the Kimpese area, Lower Congo, D.R. Congo Santé 13: 39-41.
10. Phanzu DM, Bafende EA, Dunda BK, Imposo DB, Kibadi AK, et al. (2006) Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg 75: 311-314.
11. World Health Organization, 2004 (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer), WHO/CDS/CPE/GBUI/2004.10, World Health Organization, Geneva.
12. World Health Organization (2001) Buruli ulcer-Diagnosis of Mycobacterium ulcerans disease. Portaels F, Johnson P, Meyers WM, eds. WHO/CDS/CPE/GBUI/2001.4, World Health Organization, Geneva.
13. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson RC, et al. (2008) Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in a semi-solid transport medium. J Clin Microbiol 46: 69-72.
14. World Health Organization, 2000 (2001) Buruli ulcer-Mycobacterium ulcerans infection. Asiedu K, Scherpbier R, Raviglione M, eds. WHO/CDS/CPE/GBUI/2001.1, World Health Organization, Geneva.
15. Habicht JP, Victoria CG, Vaughan JP, (1999) Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int J Epid 28: 10-18.
16. Renzaho AM, Woods PV, Ackumey MM, Harvey SK, Kotin J, (2007) Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana. Trop Med Int Health 12: 445-458.
17. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis 10: 1391-1398.
18. Sizaire V, Nackers F, Comte E, Portaels F, (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 6: 288-296.
19. Portaels F, Johnson RC, Aguiar J, Meyers WM, Debacker M, (2008) Etude de 106 cas d'ulcères de Buruli avec atteintes osseuses traités à Zagnanado, Bénin. Bull ALLF 23: 48-50.
20. Stienstra Y, van der Graaf WT, Asamoa K, van der Werf TS, (2002) Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg 67: 207-213.
21. Kibadi K, Boelaert M, Kayinua M, Minuku JB, Muyembe-Tamfum JJ, et al. (2009) Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo. Trop Med Int Health 14: 1110-1116.
22. Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, et al. (2004) Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg 70: 520-526.
23. Aujoulat I, Johnson C, Zinsou C, Guedenon A, Portaels F, (2003) Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin. Trop Med Int Health 8: 750-759.
24. Johnson RC, Makoutode M, Hougnihin R, Guedenon A, Ifebe D, et al. (2004) Traditional treatment for Buruli ulcer in Benin. Méd Trop 64: 145-150.
25. Mulder AA, Boerma RP, Barogui Y, Zinsou C, Johnson RC, et al. (2008) Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg 102: 912-920.
26. Johnson PD, Stinear T, Small PL, Pluschke G, Merritt RW, et al. (2005) Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PloS Med 2: e108.
27. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186.
28. Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, et al. (2010) Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375: 664-672.
29. Grietens KP, Boock AU, Peeters H, Hausmann-Muela S, Toomer E, et al. (2008) "It is me who endures but my family that suffers": social isolation as a consequence of the household cost burden of Buruli ulcer free of charge hospital treatment. PloS Negl Trop Dis 2: e321.
30. WHO (2008) Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 83: 145-154.